Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats - PubMed (original) (raw)
Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats
O Z Chi et al. Anesth Analg. 1997 Feb.
Abstract
We performed this study to evaluate the effects of changing the level of nitric oxide (NO) on disruption of the blood-brain barrier (BBB) by hyperosmolar mannitol. Under isoflurane anesthesia, control rats (control group, n = 6) were given infusions with 25% mannitol into the internal carotid artery before measuring the transfer coefficient (Ki) of 14C-alpha-aminoisobutyric acid (14C-AIB). In the CAS group (n = 6), [3-(cis-2,6-dimethyl piperidino)-sydnonimine] (CAS 754), a NO donor, was injected to decrease the mean arterial pressure (MAP) to 55 mm Hg and in the L-NAME group (n = 6), NG-nitro-L-arginine methyl ester (L-NAME), a NO synthase inhibitor, was injected before administering mannitol. In additional control animals (control + P group, n = 6) and additional CAS 754-treated animals (CAS + P group, n = 6), phenylephrine was infused to keep MAP at 130 mm Hg during the experimental period. In the control group, with mannitol injection, the Ki of the ipsilateral cortex (IC) where mannitol was injected increased to 4.3 times that of the contralateral cortex (CC) (17.2 +/- 2.9 vs 4.0 +/- 2.6 microliters.g-1.min.1). Without blood pressure control, the Ki of the IC of the CAS group (7.0 +/- 4.5) was lower and that of the L-NAME group (26.2 +/- 12.7) was higher than that of the control animals. At the same MAP, the Ki of the IC of the CAS + P group (9.6 +/- 3.1) was significantly lower than that of the control + P group (21.3 +/- 14.5) or that of the L-NAME group. There was no significant difference in the Ki of the IC between the control + P and the L-NAME groups. In conclusion, L-NAME worsened BBB disruption induced by hyperosmolar solution, which may be due to the pressure effect of L-NAME. CAS 754 was effective in attenuating disruption of the BBB caused by hyperosmolar mannitol. This effect is apparently not due to decreased MAP.
Similar articles
- The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ, Chun TW, Liu X, Weiss HR. Chi OZ, et al. Anesth Analg. 1998 Jun;86(6):1230-5. doi: 10.1097/00000539-199806000-00018. Anesth Analg. 1998. PMID: 9620510 - Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
Chi OZ, Hunter C, Liu X, Weiss HR. Chi OZ, et al. Neurol Res. 2005 Dec;27(8):864-8. doi: 10.1179/016164105X49418. Neurol Res. 2005. PMID: 16354548 - Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ, Lu X, Wei HM, Williams JA, Weiss HR. Chi OZ, et al. Anesth Analg. 1996 Aug;83(2):336-41. doi: 10.1097/00000539-199608000-00023. Anesth Analg. 1996. PMID: 8694315 - Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance.
Chu C, Jablonska A, Gao Y, Lan X, Lesniak WG, Liang Y, Liu G, Li S, Magnus T, Pearl M, Janowski M, Walczak P. Chu C, et al. Nat Protoc. 2022 Jan;17(1):76-94. doi: 10.1038/s41596-021-00634-x. Epub 2021 Dec 13. Nat Protoc. 2022. PMID: 34903870 Free PMC article. Review.
Cited by
- Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells.
Song H, Cheng Y, Bi G, Zhu Y, Jun W, Ma W, Wu H. Song H, et al. PLoS One. 2016 Feb 16;11(2):e0149269. doi: 10.1371/journal.pone.0149269. eCollection 2016. PLoS One. 2016. PMID: 26881424 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources